Arjun Jayadev, economics professor at Azim Premji University in Bangalore, India, and Achal Prabhala, coordinator of the AccessIBSA project, discusses the urgency of waiving intellectual property protections for vaccines, particularly in light of the on-going COVID-19 pandemic in India and other developing countries.